Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mersana Therapeutics Inc (MRSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 439,909
  • Shares Outstanding, K 22,900
  • Annual Sales, $ 17,550 K
  • Annual Income, $ -38,710 K
  • 36-Month Beta N/A
  • Price/Sales 25.08
  • Price/Cash Flow N/A
  • Price/Book 8.03

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.72 +40.01%
on 06/07/18
23.96 -19.82%
on 05/29/18
-0.85 (-4.24%)
since 05/22/18
3-Month
13.72 +40.01%
on 06/07/18
23.96 -19.82%
on 05/29/18
+1.45 (+8.16%)
since 03/22/18
52-Week
12.45 +54.30%
on 02/09/18
23.96 -19.82%
on 05/29/18
+5.21 (+37.21%)
since 06/28/17

Most Recent Stories

More News
Investor Expectations to Drive Momentum within The Kroger, Mohawk Industries, Mersana Therapeutics, Riot Blockchain, Snap, and The Sherwin-Williams -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Kroger Co. (NYSE:KR), Mohawk...

MHK : 211.87 (+0.46%)
SHW : 396.13 (+0.19%)
MRSN : 19.21 (+3.00%)
KR : 29.69 (+3.34%)
RIOT : 6.88 (-5.36%)
SNAP : 13.20 (-0.30%)
Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018

Favorable Tolerability Profile and Early Signs of Efficacy Demonstrated

MRSN : 19.21 (+3.00%)
Mersana Therapeutics to Present at the Jefferies Global Healthcare Conference

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin(R) and other...

MRSN : 19.21 (+3.00%)
Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1522 at the 2018 American Society of Clinical Oncology Annual Meeting

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin and other...

MRSN : 19.21 (+3.00%)
Mersana Therapeutics Announces First Quarter 2018 Financial Results and Provides Business Updates

Phase 1 Dose Escalation Trials Progressing for Lead Programs XMT-1522 and XMT-1536

MRSN : 19.21 (+3.00%)
Mersana Therapeutics to Host Conference Call Announcing First Quarter 2018 Financial Results and Business Updates

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin and other...

MRSN : 19.21 (+3.00%)
Mersana Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin and other...

MRSN : 19.21 (+3.00%)
DB : 11.01 (+1.10%)
Wired News - Krystal Biotech's Lead Product Candidate, KB103, for Treatment of DEB Receives Orphan Medicinal Product Designation in Europe

Stock Monitor: Mersana Therapeutics Post Earnings Reporting

MRSN : 19.21 (+3.00%)
Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability

MRSN : 19.21 (+3.00%)
Mersana Therapeutics Announces Poster Presentations Demonstrating Differentiating Aspects of ADC Platform Technology at the American Association for Cancer Research Annual Meeting 2018

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin(R) and other...

MRSN : 19.21 (+3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade MRSN with:

Business Summary

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

2nd Resistance Point 20.10
1st Resistance Point 19.65
Last Price 19.21
1st Support Level 18.57
2nd Support Level 17.93

See More

52-Week High 23.96
Fibonacci 61.8% 19.56
Last Price 19.21
Fibonacci 50% 18.20
Fibonacci 38.2% 16.85
52-Week Low 12.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar